CLOV Stock Analysis: Buy, Sell, or Hold?
CLOV - Clover Health Investments, Corp
$3.47
-0.02 (-0.57%)
▼
5d:
+11.22%
30d:
+60.65%
90d:
+71.78%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Smart Money Distribution
None View Scanner →
Strength: 10.0/10
Get Alerted When CLOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
31 traders called CLOV this week
92% bullish • 3 bearish
92% bullish • 3 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CLOV is 14.5% above its trading range ($3.03). Market expects 5.9% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CLOV is 14.5% above its trading range ($3.03). Market expects 5.9% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CLOV is currently trading at $3.47, which is considered extended relative to its 30-day fair value range of $2.04 to $3.03. From a valuation perspective, the stock is trading at a premium (Forward PE: 38.8) compared to its historical average (32.7). At these levels, the market is pricing in 5.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CLOV is in a downtrend. Immediate support is located at $2.57, while resistance sits at $3.70.
Market Sentiment: CLOV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $2.82. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLOV is in a downtrend. Immediate support is located at $2.57, while resistance sits at $3.70.
Market Sentiment: CLOV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $2.82. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.04 -
$3.03
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
41.9%
Protect Your Profits
CLOV is technically overbought (RSI 77). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+14.5% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 19.3% above Wall St target ($2.82)
- NEUTRAL: Trading at premium valuation - market expects 5.9% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$2.04 -
$3.03
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.57
Resistance Level
$3.70
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
38.78
Wall Street Target
$2.82
(-19.3%)
Revenue Growth (YoY)
62.0%
Profit Margin
-2.6%
Valuation Premium vs History
+5.9% premium
PE vs Historical
38.8 vs 32.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.9%
(market-implied from PE analysis)
1-Year Target
$3.70
(+6%)
2-Year Target
$3.91
(+12%)
3-Year Target
$4.14
(+19%)
3-Yr Target (if PE normalizes)
(PE: 39→33)
PE COMPRESSION
$3.50
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 38.8, Growth: 12.5%)
$4.97
(+42%)
Base:
(SPY PE: 22.0, Growth: 12.5%)
$2.82
(-19%)
Bear:
(PE: 18.7, Growth: 12.5%)
$2.40
(-31%)
Share & Embed Analysis
Last updated: May 15, 2026 4:52 PM ET
Data refreshes hourly during market hours. Next update: 5:52 PM
Data refreshes hourly during market hours. Next update: 5:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLOV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Brady Patrick Priest
SELL
175000 shares
2026-03-04
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$100 | 58 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$387 | 62 BUY |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 65 BUY |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$389 | 57 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$244 | 57 HOLD |
Advanced CLOV Option Strategies
Professional options setups generated by AI based on today's CLOV price and gamma walls.
